RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCC

Clinical Trial ID NCT02678013

PubWeight™ 0.81‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02678013

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Management of hepatocellular carcinoma: an update. Hepatology 2011 33.57
2 Immunotherapy in hepatocellular carcinoma: Primed to make a difference? Cancer 2015 0.91
3 A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma. Br J Cancer 2015 0.85
4 Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology 2016 0.81
Next 100